Have Sars Antibodies Been Developed

SARS antibody-80R (IgG)
E24CHA001 Human-,-Human-IgG1.
EUR 276.5
Description: Human , Human IgG1.

Human IgG antibody Laboratories manufactures the have sars antibodies been developed reagents distributed by Genprice. The Have Sars Antibodies Been Developed reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Have products are available in stock. Specificity: Have Category: Sars Group: Antibodies Been

Human Platelet Antibodies IgG (PA-IgG) ELISA Kit
10x96-Strip-Wells
EUR 6725

Human Platelet Antibodies IgG (PA-IgG) ELISA Kit
48-Strip-Wells
EUR 550

Human Platelet Antibodies IgG (PA-IgG) ELISA Kit
5x96-Strip-Wells
EUR 3420

Human Platelet Antibodies IgG (PA-IgG) ELISA Kit
96-Strip-Wells
EUR 765

Human Platelet IgG antibodies (PA-IgG) ELISA Kit
10x96-Strip-Wells
EUR 6255

Human Platelet IgG antibodies (PA-IgG) ELISA Kit
48-Strip-Wells
EUR 445

Human Platelet IgG antibodies (PA-IgG) ELISA Kit
5x96-Strip-Wells
EUR 3290

Antibodies Been information

Humanized SARS_COV2 (Spike) antibodies
MBS460946-5x01mg 5x0.1mg
EUR 1355

SARS-CoV-2 Spike Trimer (B.1.617.2) Specific ELISA Kit (For Vaccine Development)
RAS-A055 96tests
EUR 861.1
  • This kit is developed for specific detection of SARS-CoV-2 Spike Protein (B.1.617.2) in vaccine samples,witch can meet the needs of vaccine developers to establish antigen quantification methods for preclinical evaluation, vaccine production and qual
  • Show more
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike Trimer (B.1.1.529) Specific ELISA Kit (For Vaccine Development)
RAS-A081 96tests
EUR 861.1
  • The kit is developed for specific detection of SARS-CoV-2 Spike Protein (B.1.1.529) in vaccine samples,witch can meet the needs of vaccine developers to establish antigen quantification methods for preclinical evaluation, vaccine production and quali
  • Show more
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike Trimer (BA.4) Specific ELISA Kit (For Vaccine Development)
RAS-A124 96tests
EUR 861.1
  • This kit is developed for specific detection of SARS-CoV-2 Spike Trimer (BA.4) in vaccine samples,witch can meet the needs of vaccine developers to establish antigen quantification methods for preclinical evaluation, vaccine production and quality co
  • Show more
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike Trimer (BA.5) Specific ELISA Kit (For Vaccine Development)
RAS-A125 96tests
EUR 861.1
  • This kit is developed for specific detection of SARS-CoV-2 Spike Trimer (BA.5) in vaccine samples,witch can meet the needs of vaccine developers to establish antigen quantification methods for preclinical evaluation, vaccine production and quality co
  • Show more
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike RBD (BA.4 & BA.5) Specific ELISA Kit (For Vaccine Development)
RAS-A126 96tests
EUR 861.1
  • This kit is developed for specific detection of SARS-CoV-2 Spike RBD (BA.4 & BA.5) in vaccine samples, witch can meet the needs of vaccine developers to establish antigen quantification methods for preclinical evaluation, vaccine production and quali
  • Show more
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Spike RBD (Wild Type) Specific ELISA Kit (For Vaccine Development)
RAS-A116 96tests
EUR 861.1
  • The kit is developed for specific detection of SARS-CoV-2 Spike RBD (Wild Type) in vaccine samples, witch can meet the needs of vaccine developers to establish antigen quantification methods for preclinical evaluation, vaccine production and quality
  • Show more
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Neutralization Assay Development Kit (Delta Variant RBD-ACE2)
NTRL-DT-RBD-10 10 x 96-well plates
EUR 2412.89
  • Coronavirus kit
Description: Neutralization kit

SARS-CoV-2 Neutralization Assay Development Kit (Indian Variant RBD-ACE2)
NTRL-IN-RBD-10 10 x 96-well plates
EUR 2412.89
  • Coronavirus kit
Description: Neutralization kit

SARS-CoV-2 Neutralization Assay Development Kit (Lambda Variant RBD-ACE2)
NTRL-LD-RBD-10 10 x 96-well plates
EUR 2412.89
  • Coronavirus kit
Description: Neutralization kit

SARS-CoV-2 Spike Trimer (Wild Type) Specific ELISA Kit (For Vaccine Development)
RAS-A115 96tests
EUR 861.1
  • The kit is developed for specific detection of SARS-CoV-2 Spike Trimer (Wild Type) in vaccine samples, witch can meet the needs of vaccine developers to establish antigen quantification methods for preclinical evaluation, vaccine production and quali
  • Show more
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective assay kit detecting the levels of SARS-CoV-2 Spike protein is urgently needed to accelerate the development of COVID-19 vaccines.

SARS-CoV-2 Neutralization Assay Development Kit (Brazilian Variant RBD-ACE2)
NTRL-BZ-RBD-10 10 x 96-well plates.
EUR 2412.89
  • Coronavirus kit
Description: Neutralization kit

SARS-CoV-2 Neutralization Assay Development Kit (Omicron Variant SPIKE-ACE2)
NTRL-OMI-SPIKE-10 10 x 96-well plates
EUR 2390.76
  • Coronavirus kit
Description: SARS-CoV-2 Neutralization Assay Development Kit (Omicron Variant Spike-ACE2)

SARS-CoV-2 Neutralization Assay Development Kit (South African Variant RBD-ACE2)
NTRL-SA-RBD-10 10 x 96-well plates
EUR 2412.89
  • Coronavirus kit
Description: Neutralization kit

HDAC developer (2X)
50030 6 ml
EUR 230
Description: HDAC assay developer is an essential reagent for signal generation in HDAC assays performed with any of BPS Bioscience's HDAC fluorimetric substrates or assay kits. An appropriate fluorimetric substrate, comprising an acetylated lysine side chain, is first incubated with a sample containing HDAC activity (nuclear or cellular extract, purified enzyme, bead-bound immunocomplex, etc.). Deacetylation of the substrate sensitizes it so that, in a second step, treatment with the HDAC assay developer produces a fluorophore. Trichostatin A is included as an 'inhibitor stop' for class I and II HDACs.

HDAC developer (2X)
GWB-ECBB10 6ml Ask for price

SARS-CoV-2 Neutralization Assay Development Kit (United Kingdom Variant RBD-ACE2)
NTRL-UK-RBD-10 10 x 96-well plates
EUR 2412.89
  • Coronavirus kit
Description: Neutralization kit